Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Rheumatoid Arthritis (RA) according to specific medical guidelines, and whose disease is currently considered active based on standard scoring measurements
- People who are older than 18 and younger than 65 years of age
- People for whom a doctor has considered treatment with filgotinib or adalimumab (two specific medications used for Rheumatoid Arthritis)
Who may not be able to join:
- People who have a history of major heart problems or stroke
- People who have previously had blood clots in their veins (such as deep vein thrombosis or pulmonary embolism)
- People who currently smoke, or people who smoked heavily in the past (more than 10 pack-years, which refers to smoking one pack of cigarettes per day for 10 years, or an equivalent amount)
- People who have had bone fractures caused by weakened bones, or who have been diagnosed with severe osteoporosis based on specific bone density measurements
- People who are currently taking certain bone-related medications, including estrogens, bisphosphonates, denosumab, teriparatide, or romosozumab
- People who have been taking moderate to high doses of steroid medications (such as prednisone at 7.5 mg per day or more) for longer than 3 months before joining the trial (confirm with trial site for details about shorter-term steroid use)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390458122574
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
micro RNA (miRNA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.